Who? cardiovascular disease. http://www.hoint/mediacentre/factsheets/fs317/en/(October 18th 2019).

Cancer W. October: http://www.who.int/mediacentre/factsheets/fs297/en/ (18th 2019).

Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: Final data for 2015. National Vital Statistics Report: From the Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System 2017;66(6):1–75.

Google Scholar

Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: Cardio-oncology. Mayo Clinic Proceedings 2014;89(9):1287–1306.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN morbidity and mortality estimates for 36 cancers in 185 countries worldwide. Cancer J Clinic. 2021;71(3):209–49.

Article Google Scholar

Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE-3 Abstract: Cancer survival in Europe at the end of the 20th century. Annals Oncology: Official J Eur Soc Med Oncol. 2003;14(Supplement 5):v128–149.

Article Google Scholar

Brusman SM, Marriott AB, Rowland JH. Predicting the Silver Tsunami: Trends in incidence and comorbidity burden among older cancer survivors in the United States. Cancer epidemiology, biomarkers, and prevention: A publication of the American Association for Cancer Research. Co-sponsored by Am Soc Prev Oncol. 2016;25(7):1029–36.

Google Scholar

De Boer RA, Myers WC, van der Meer P, van Veldhuizen DJ. Cancer and heart disease: links and relationships. Eur J heart failure. 2019;21(12):1515–25.

Article PubMed Google Scholar

Koene RJ, Prizement AE, Blaes A, Konety SH. Common risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–14.

Article PubMed PubMed Central Google Scholar

Lyon AR, López-Fernández T, Couch LS, Astejano R, Asner MC, Bergler-Klein J, Bogliani G, Cardinale D, Córdoba R, Cossins B et al. The 2022 ESC guidelines for cardio-oncology are published by the European Society of Hematology (EHA); Developed in collaboration with the European Society for Radiation Therapy Oncology (ESTRO) and the International Society of Cardio-Oncology (IC-OS). Eur Heart J. 2022;43(41):4229–361.

Article PubMed Google Scholar

Zamorano JL, Lancelotti P, Rodríguez Muñoz D, Aboyans V, Astellano R, Galderisi M, Habib G, Lenihan DJ, Ripp GYH, Lyon AR, 2016 ESC Position Paper on Other Cancer Treatments and Cardiovascular Toxicity. It was prepared under the auspices of the European Society of Cardiology (ESC) Task Force on Cancer Treatment and Cardiovascular Toxicity, the ESC Clinical Practice Guidelines Committee. Eur Heart J. 2016;37(36):2768–801.

Article PubMed Google Scholar

Lancelotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, van der Meer P, Cohen-Solar A, Zamorano JL, Jerusalem G, Moonen M, et al. Cardio-oncology services: rationale, organization, and implementation. Eur Heart J. 2019;40(22):1756–63.

Article PubMed Google Scholar

del Pozo Cruz B, Ahmadi MN, Lee IM, Stamatakis E. Prospective association of daily step count and step count with cancer and cardiovascular disease incidence, mortality, and all-cause mortality. JAMA intern doctor. 2022;182(11):1139–48.

Article PubMed PubMed Central Google Scholar

Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat reviews Cardiol. 2022;19(2):133–43.

Article Google Scholar

Wang Y, Liu B, Han H, Hu Y, Zhu L, Rimm EB, Hu FB, Sun Q. Associations between plant-based dietary patterns and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality – Systematic. review and meta-analysis. Nutr J. 2023;22(1):46.

Article CAS PubMed PubMed Central Google Scholar

Curtin LR, Mohajer LK, Dorman SM, Montaquila JM, Cruzan-Moran D, Mirel LB, Carroll MD, Hirsch R, Schober S, Johnson CL. National Health and Nutrition Examination Survey: Sample design, 1999–2006. Demographic and Health Statistics Series 2, Data Evaluation and Methodology Research 2012(155):1–39.

Curtin LR, Mohajer LK, Dorman SM, Curzon-Moran D, Mirel LB, Carroll MD, Hirsch R, Burt VL, Johnson CL. National Health and Nutrition Examination Survey: Sample design, 2007–2010. Vital Health Stat Ser 2 Data Evaluation Methodology Res 2013(160):1–23.

Johnson CL, Dorman SM, Burt VL, Mohajer LK. National Health and Nutrition Examination Survey: Sample Design, 2011-2014. Vital Health Stat Ser 2 Data Evaluation Methods Res 2014(162):1–33.

Chen TC, Clark J, Riddles MK, Mohajar LK, Fakhouri THI. National Health and Nutrition Examination Survey, 2015–2018: Sample design and estimation procedures. Vital Health Stat Ser 2 Data Evaluation Methods Res 2020(184):1–35.

Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. Human exposome and phenome database from the US National Health and Nutrition Examination Survey. scientific data. 2016;3:160096.

Article CAS PubMed PubMed Central Google Scholar

Centers for Disease Control and Prevention (CDC). About the National Health and Nutrition Survey. 2017 https://www.cdcgov/nchs/nhanes/about_nhaneshtm.

Johnson CL, Paulos-Lamb R, Ogden CL, Carroll MD, Curzon-Moran D, Dorman SM, Curtin LR. National Health and Nutrition Examination Survey: Analysis Guidelines, 1999-2010. Vital Health Stat Ser 2 Data Evaluation Methods Res 2013(161):1–24.

Pan S, Chen S. Empirical comparison of imputation methods for multivariate missing data in public health. Int J Environ Res Public Health 2023, 20(2).

Riley JP, Beatty JM. Palliative care in heart failure: facts and figures. ESC heart failure. 2017;4(2):81–7.

Article PubMed Google Scholar

Springer J, Springer JI, Anker SD. Muscle atrophy and sarcopenia in heart failure and beyond: 2017 update. ESC heart failure. 2017;4(4):492–8.

Article PubMed PubMed Central Google Scholar

Saito M, dos Santos MR, Emami A, Ishida J, Ebner N, Valentova M, Bekfany T, Sandek A, Reinssak M, Dorner W, et al. Anorexia, functional capacity, and clinical outcomes in patients with chronic heart failure: Results from a study examining comorbidities that exacerbate heart failure (SICA-HF). ESC heart failure. 2017;4(4):448–57.

Article PubMed PubMed Central Google Scholar

von Haehling S. Heart failure comorbidities are beginning to emerge, but no end in sight? Eur J Heart failure. 2017;19(12):1566–8.

Article Google Scholar

Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC. Association between CKD and cancer risk in the elderly. J Am Soc Nephrology: JASN. 2009;20(6):1341–50.

Article CAS PubMed Central Google Scholar

Hassin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Sirhan JR, Rodger VL. Patients with heart failure are at increased risk of developing cancer. J Am Col Cardiol. 2013;62(10):881–6.

Article PubMed PubMed Central Google Scholar

Hassin T, Gerber Y, Weston SA, Jiang R, Killian JM, Maneman SM, Sirhan JR, Roger VL. Heart failure after myocardial infarction is associated with increased risk of cancer. J Am Col Cardiol. 2016;68(3):265–71.

Article PubMed PubMed Central Google Scholar

Banke A, Schou M, Videbaek L, Møller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Køber L, Hildebrandt PR, Gislason GH. Cancer incidence in patients with chronic heart failure: a long-term follow-up study. Eur J heart failure. 2016;18(3):260–6.

Article PubMed Google Scholar

Malhotra J, Boffetta P. Association between increased cancer risk and heart failure. J Am Col Cardiol. 2016;68(3):272–3.

Article PubMed Google Scholar

Myers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, Yong Sd, Haubner BJ, Nagengast WB, Lyon AR, Becht Bvd. Heart failure stimulates tumor growth by circulating factors. Circulation. 2018;138(7):678–91.

Article CAS PubMed Google Scholar

Cuomo A, Pirozzi F, Attanasio U, Franco R, Elia F, DeRosa E, Russo M, Guigo A, Ameri P, Tochetti CG, et al. Cancer risk in the heart failure population: epidemiology, mechanisms, and clinical implications. Curr Oncol Rep. 2020;23(1):7.

Article PubMed PubMed Central Google Scholar

Soman A, Asha Nair S. Unraveling the SERPINA3 cascade: from inflammation to cancer. Biochim et Biophys Acta (BBA) – Cancer Review. 2022;1877(5):188760.

Article CAS Google Scholar

Ausoni S, Azzarello G. Cancer development in heart failure patients: how systemic inflammation lays the foundation. Frontiers of Cardiovascular Medicine 2020, 7.

Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzaki T. Association of gut-associated metabolites with acute heart failure outcome. Am Heart J. 2021;234:71–80.

Article CAS PubMed Google Scholar

Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, et al. The sympathetic nervous system induces the metastatic switch in primary breast cancer. Cancer Research Institute 2010;70(18):7042–52.

Article CAS PubMed PubMed Central Google Scholar

Van Bilsen M, Patel HC, Bauersachs J, Boehm M, Borggraeve M, Bruzart D, Coates AJS, de Boer RA, de Keuliner GW, Philippatos GS, et al. The autonomic nervous system as a therapeutic target for heart failure: a scientific position statement of the European Society of Cardiology Heart Failure Association Translational Research Committee. Eur J heart failure. 2017;19(11):1361–78.

Article PubMed Google Scholar

Cho IJ, Shin JH, Chung MH, Kang CY, Hwang J, Kwon CH, Kim W, Kim DH, Lee CJ, Kang SH Other antihypertensive drugs and cancer risk: a national cohort the study. J Clin Med 2021, 10(4).

Barbarata CI, Tefas LR, Achim M, Tomta I, Porfire AS. Statins in cancer risk reduction and treatment. World J Clin Oncol. 2020;11(8):573–88.

Article PubMed PubMed Central Google Scholar

Ricco N, Kron SJ. Statins in cancer prevention and treatment. Cancer 2023, 15(15).

Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: drugs repurposed to fight cancer. J Experimental and Clinical Cancer Research Institute. 2021;40(1):241.

Article CAS Google Scholar

Zhou Q, Jiao Z, Liu Y, Devreotes PN, Zhang Z. Effects of statins in patients with advanced stage cancer – a systematic review and meta-analysis. Front Oncor 2023, 13.

Matsevich L, Chogala A, Sikorsky AF. Attempts to use statins to treat cancer: An update. Tumor biology. 2020;42(7):1010428320941760.

Article PubMed Google Scholar